ALK to Unveil First Quarter 2025 Results
ALK (ALKB.DC / OMX: ALK B) is set to release its financial performance highlights for the first quarter of 2025. This key disclosure will occur in the morning of May 6, giving investors and analysts an early overview of the company's direction.
Engaging Investor Presentation Scheduled
That same day, at 11:00 a.m. CEST, ALK’s management will host a presentation for investors and analysts. During this session, leadership, including Peter Halling (President & CEO), Claus Steensen Sølje (CFO), and Per Plotnikof (VP, Head of IR), will discuss the company’s results and outlook.
Participate via Live Audio Webcast
For those interested in following the presentation, ALK will provide a live audio webcast where participants can listen in on the discussions and insights shared by the management team. This webcast will also be accessible for replay on ALK's official website after the event.
Join the Conversation Through Conference Call
If you prefer to participate through a telephone conference call, please ensure you register beforehand. Registration can be completed through a designated link, after which you'll receive an email containing dial-in details, including a passcode and pin number. To avoid any issues receiving this information, make sure to whitelist the email address from which the call details will be sent.
Availability of Presentation Materials
Shortly ahead of the presentation, relevant materials, such as slides and other essential documents, will be made available online. This provision allows all participants to follow along effectively and gain full insights into ALK’s strategies and results.
About ALK
ALK is recognized as a prominent global specialty pharmaceutical company concentrating on allergy and allergic asthma treatments. The company markets various allergy immunotherapy solutions and related services intended for both patients and healthcare professionals. With a workforce of approximately 2,800 individuals worldwide, ALK proudly maintains its headquarters in Hørsholm, Denmark, and is listed on Nasdaq Copenhagen.
For More Information
For any further inquiries, individuals can reach out to the Investor Relations contact, Per Plotnikof at +45 4574 7527 or +45 2261 2525. Media-related questions can be directed to Maiken Riise Andersen at +45 5054 1434.
Frequently Asked Questions
What is the date of ALK's Q1 2025 results announcement?
ALK will announce its Q1 2025 results on May 6, in the morning.
How can I attend ALK’s investor presentation?
You can attend the presentation via a live audio webcast accessible on ALK's official website.
Who will represent ALK during the investor call?
Peter Halling, Claus Steensen Sølje, and Per Plotnikof will represent the company during the call.
Will the presentation materials be available after the event?
Yes, the presentation materials will be available on ALK’s website shortly before the meeting starts.
How do I contact ALK for further information?
You can contact Per Plotnikof at +45 4574 7527 for investor relations, or Maiken Riise Andersen at +45 5054 1434 for media inquiries.
